Zhang Yi-bang, Shi Li-nan, Chang Shao-hong, Gong Xin, Xiong Ling-shuang, Wu Jun
Beijing Institute of Biotechnology, Beijing 100071, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Jun;23(6):515-9.
To find if human soluble tumor necrosis factor receptor II (p75) fused IgG Fc protein (sTNFR II-IgG Fc) could be expressed in Pichia pastoris with an active dimmer form and characterize its N-linked oligosaccharides.
Two gene fragment, human sTNFR II and IgGFc, were got by RT-PCR from leucocytes stimulated with LPS. And the chimeric gene sTNFR II-IgG Fc achieved through gene splicing by over lap extension (SOE) method was cloned into pPIC9 and transformed into methanotropic yeast Pichia pastoris. The fusion protein purified by Protein A affinity column was analyzed with SDS-PAGE electrophoresis under reducing or non-reducing conditions and immunological methods. The anti-TNF-alpha biological activity assay of fusion protein was performed with L929 cells and detected with MTT colorimetry. The N-linked oligosaccharides hydrolyzed from fusion protein were labeled with 8-amino-1, 3, 6-naphthalene trisulfonic acid (ANTS) were analyzed with fluorophore-assisted carbohydrate eletrophoresis (FACE) as well.
The recombinant P. pastoris strain that expressed human sTNFR II-IgG Fc fusion protein was constructed. The expression level of fusion protein in 2 L flask reached 2 mg/L. SDS-PAGE and Western blot showed the expressed fusion protein purified by protein was a dimer linked with inter-molecular disulfide linkage. The fusion protein neutralized cytotoxic activity of TNF-alpha to L929 cells, and the EC(50) of the fusion protein to inhibit 5 x 10(4) U/L of TNF-alpha was 170 microg/L. The FACE analysis showed there are 11 to 13 hexoses on each N-linked oligosaccharide.
The human sTNFR II-IgG Fc fusion protein is expressed successfully in P. pastoris and it could be a reference for the future expression of other Fc fusion proteins or immunoglobulins in Pichia pastoris.
探究人可溶性肿瘤坏死因子受体II(p75)融合IgG Fc蛋白(sTNFR II-IgG Fc)能否在毕赤酵母中以活性二聚体形式表达,并对其N-连接寡糖进行表征。
通过RT-PCR从经脂多糖刺激的白细胞中获取人sTNFR II和IgGFc两个基因片段。采用重叠延伸基因拼接(SOE)法获得嵌合基因sTNFR II-IgG Fc,将其克隆至pPIC9并转化至嗜甲醇酵母毕赤酵母中。用蛋白A亲和柱纯化融合蛋白,在还原或非还原条件下通过SDS-PAGE电泳及免疫学方法进行分析。用L929细胞进行融合蛋白的抗TNF-α生物学活性测定,并用MTT比色法检测。从融合蛋白水解得到的N-连接寡糖用8-氨基-1,3,6-萘三磺酸(ANTS)标记,并用荧光辅助碳水化合物电泳(FACE)进行分析。
构建了表达人sTNFR II-IgG Fc融合蛋白的重组毕赤酵母菌株。融合蛋白在2 L摇瓶中的表达水平达到2 mg/L。SDS-PAGE和Western印迹显示,经蛋白纯化的表达融合蛋白为通过分子间二硫键连接的二聚体。融合蛋白中和了TNF-α对L929细胞的细胞毒性活性,融合蛋白抑制5×10⁴ U/L TNF-α的半数有效浓度(EC₅₀)为170 μg/L。FACE分析显示每个N-连接寡糖上有11至13个己糖。
人sTNFR II-IgG Fc融合蛋白在毕赤酵母中成功表达,可为未来在毕赤酵母中表达其他Fc融合蛋白或免疫球蛋白提供参考。